These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9564447)

  • 1. Antipanic effect of fluoxetine measured by CO2 challenge test.
    Bocola V; Trecco MD; Fabbrini G; Paladini C; Sollecito A; Martucci N
    Biol Psychiatry; 1998 Apr; 43(8):612-5. PubMed ID: 9564447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antipanic treatment on response to carbon dioxide.
    Gorman JM; Browne ST; Papp LA; Martinez J; Welkowitz L; Coplan JD; Goetz RR; Kent J; Klein DF
    Biol Psychiatry; 1997 Dec; 42(11):982-91. PubMed ID: 9386849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group.
    Michelson D; Pollack M; Lydiard RB; Tamura R; Tepner R; Tollefson G
    Br J Psychiatry; 1999 Mar; 174():213-8. PubMed ID: 10448445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of successful treatment on the emotional and physiological response to carbon dioxide inhalation in patients with panic disorder.
    Gorman JM; Martinez J; Coplan JD; Kent J; Kleber M
    Biol Psychiatry; 2004 Dec; 56(11):862-7. PubMed ID: 15576063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventilatory response to CO2 in panic disorder.
    Zandbergen J; Pols H; de Loof C; Griez EJ
    Psychiatry Res; 1991 Oct; 39(1):13-9. PubMed ID: 1771205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopathological profile of 35% CO2 challenge test-induced panic attacks: a comparison with spontaneous panic attacks.
    Nardi AE; Valença AM; Lopes FL; Nascimento I; Veras AB; Freire RC; Mezzasalma MA; de-Melo-Neto VL; Zin WA
    Compr Psychiatry; 2006; 47(3):209-14. PubMed ID: 16635650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder.
    Coplan JD; Papp LA; Pine D; Martinez J; Cooper T; Rosenblum LA; Klein DF; Gorman JM
    Arch Gen Psychiatry; 1997 Jul; 54(7):643-8. PubMed ID: 9236548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of escitalopram on anxiety and respiratory responses to carbon dioxide inhalation in subjects at high risk for panic disorder: a placebo-controlled, crossover study.
    Coryell W; Rickels H
    J Clin Psychopharmacol; 2009 Apr; 29(2):174-8. PubMed ID: 19512981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon dioxide induced panic attack in panic disorder in Japan.
    Sasaki I; Akiyoshi J; Sakurai R; Tsutsumi T; Ono H; Yamada K; Fujii I
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Oct; 20(7):1145-57. PubMed ID: 8938816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extinction of panicogenic effects of a 35% CO2 challenge in patients with panic disorder.
    Schmidt NB; Trakowski JH; Staab JP
    J Abnorm Psychol; 1997 Nov; 106(4):630-8. PubMed ID: 9358693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-voxel 1H-MRS investigation of brain metabolic changes during lactate-induced panic.
    Dager SR; Richards T; Strauss W; Artru A
    Psychiatry Res; 1997 Dec; 76(2-3):89-99. PubMed ID: 9522401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder.
    Coplan JD; Papp LA; Martinez J; Pine D; Rosenblum LA; Cooper T; Liebowitz MR; Gorman JM
    Am J Psychiatry; 1995 Apr; 152(4):619-22. PubMed ID: 7694915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after 1 week of treatment with citalopram: an open study.
    Bertani A; Caldirola D; Bussi R; Bellodi L; Perna G
    J Clin Psychopharmacol; 2001 Jun; 21(3):262-7. PubMed ID: 11386488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
    Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD
    Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory panic disorder subtype and sensitivity to the carbon dioxide challenge test.
    Valenca AM; Nardi AE; Nascimento I; Zin WA; Versiani M
    Braz J Med Biol Res; 2002 Jul; 35(7):783-8. PubMed ID: 12131917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon dioxide test as an additional clinical measure of treatment response in panic disorder.
    Valença AM; Nardi AE; Nascimento I; Zin WA; Versiani M
    Arq Neuropsiquiatr; 2002 Jun; 60(2-B):358-61. PubMed ID: 12131931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a suffocation alarm system sensitive to clinically-effective treatments with the panicolytics clonazepam and fluoxetine.
    Schimitel FG; Müller CJ; Tufik S; Schenberg LC
    J Psychopharmacol; 2014 Dec; 28(12):1184-8. PubMed ID: 25277323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patients.
    Tiffon L; Coplan JD; Papp LA; Gorman JM
    J Clin Psychiatry; 1994 Feb; 55(2):66-9. PubMed ID: 8077156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory psychophysiology of panic disorder: three respiratory challenges in 98 subjects.
    Papp LA; Martinez JM; Klein DF; Coplan JD; Norman RG; Cole R; de Jesus MJ; Ross D; Goetz R; Gorman JM
    Am J Psychiatry; 1997 Nov; 154(11):1557-65. PubMed ID: 9356564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon dioxide hypersensitivity, hyperventilation, and panic disorder.
    Papp LA; Klein DF; Gorman JM
    Am J Psychiatry; 1993 Aug; 150(8):1149-57. PubMed ID: 8392296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.